TRINETRA › Sectors › Healthcare
Aster DM Quality Care Limited (ASTERDM) — share price, P/E and fundamentals
Aster DM Quality Care Limited (NSE: ASTERDM) closed at ₹681.15 on 30 Oct 2026, -3.0% over one year, against a 52-week range of ₹519.10 – ₹891.30.
In the quarter ended 30 Jun 2026 (consolidated, filed 5 Aug 2026) it reported revenue of ₹1,311 cr and net profit of ₹16 cr, a 1.2% net margin; revenue grew 21.6% and profit fell 39.2% year on year.
On four consecutive filed quarters its trailing P/E is 110.8; since 21 May 2025 its own P/E has ranged from 83.9 to 140.7 (median 102.6), and today's reading is higher than 80% of those 357 trading days.
From the balance sheet dated 31 Mar 2026: return on equity 1.4%, ROCE 6.6%, debt-to-equity 0.15, Piotroski F-score 5 of 9.
Against 65 Healthcare peers on NSE: Net margin higher than 5% of 63 sector peers; PBT margin higher than 13% of 63 sector peers; ROE higher than 6% of 63 sector peers.
Key figures
| Last close | ₹681.15 (30 Oct 2026) |
|---|---|
| Change 1 month / 6 months / 1 year | -11.4% / -3.4% / -3.0% |
| 52-week low – high | ₹519.10 – ₹891.30 |
| Market capitalisation | ₹35,292 cr |
| Trailing P/E | 110.8 |
| Price / book | 7.71 |
| EV / EBITDA | 37.9 |
| Earnings yield | 0.9% |
| TTM EPS | ₹6.15 |
| TTM net profit | ₹319 cr |
| Quarter revenue | ₹1,311 cr |
| Quarter net profit | ₹16 cr |
| Net margin | 1.2% |
| Revenue growth (YoY) | +21.6% |
| Profit growth (YoY) | -39.2% |
| Return on equity | 1.4% |
| ROCE | 6.6% |
| Debt / equity | 0.15 |
| Current ratio | 1.99 |
| Free cash flow | ₹187 cr |
| Piotroski F-score | 5 / 9 |
| Average daily turnover (50 days) | ₹80.8 cr |
Against Healthcare peers
| Metric | ASTERDM | Peer median | Percentile |
|---|---|---|---|
| Net margin | 1.23 | 12.89 | 5 |
| PBT margin | 6.60 | 17.68 | 13 |
| ROE | 1.40 | 13.87 | 6 |
| ROCE | 6.60 | 17.26 | 11 |
| Debt / equity | 0.15 | 0.11 | 58 |
| Cash conversion | 1.54 | 1.25 | 74 |
| Trailing P/E | 110.75 | 43.07 | 95 |
| P/B | 7.71 | 5.88 | 69 |
Questions
What is the P/E ratio of Aster DM Quality Care Limited?
Aster DM Quality Care Limited's trailing P/E is 110.8, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Jun 2026. Since 21 May 2025 its P/E has ranged 83.9–140.7.
What were Aster DM Quality Care Limited's latest quarterly results?
For the quarter ended 30 Jun 2026, Aster DM Quality Care Limited reported revenue of ₹1,311 cr and net profit of ₹16 cr (consolidated), filed with the exchange on 5 Aug 2026.
What is Aster DM Quality Care Limited's ROE?
Return on equity is 1.4% based on the balance sheet dated 31 Mar 2026.
Does Aster DM Quality Care Limited have debt?
Debt-to-equity is 0.15 on the balance sheet dated 31 Mar 2026.
What is ASTERDM's 52-week high and low?
Over the last 52 weeks to 30 Oct 2026, ASTERDM traded between ₹519.10 and ₹891.30.
Other Healthcare stocks
- Sun Pharmaceutical Industries Limited (SUNPHARMA)
- Divi's Laboratories Limited (DIVISLAB)
- Torrent Pharmaceuticals Limited (TORNTPHARM)
- Laurus Labs Limited (LAURUSLABS)
- Zydus Lifesciences Limited (ZYDUSLIFE)
- Apollo Hospitals Enterprise Limited (APOLLOHOSP)
- Dr. Reddy's Laboratories Limited (DRREDDY)
- Cipla Limited (CIPLA)
- Mankind Pharma Limited (MANKIND)
- Aurobindo Pharma Limited (AUROPHARMA)
- Lupin Limited (LUPIN)
- Max Healthcare Institute Limited (MAXHEALTH)
Source: consolidated SEBI Integrated Filing for the quarter ended 30 Jun 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.
TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.